LENZ Therapeutics (LENZ) Enterprise Value Growth (1y) (2021 - 2026)
LENZ Therapeutics (LENZ) Enterprise Value Growth (1y) (2021 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
| 10 |
LENZ Therapeutics |
192.19 Mn |
192.19 Mn |
825,000.00 |
| Date | Value |
|---|
| Mar 31, 2026 |
-1,015.84% |
| Dec 31, 2025 |
-1,342.12% |
| Sep 30, 2025 |
6.88% |
| Jun 30, 2025 |
55.18% |
| Mar 31, 2025 |
88.45% |
| Dec 31, 2024 |
69.19% |
| Sep 30, 2024 |
7.21% |
| Jun 30, 2024 |
65.89% |
| Mar 31, 2024 |
0.89% |
| Dec 31, 2023 |
75.47% |
| Sep 30, 2023 |
19.78% |
| Jun 30, 2023 |
23.47% |
| Mar 31, 2023 |
40.37% |
| Dec 31, 2022 |
28.85% |
| Sep 30, 2022 |
26.15% |
| Jun 30, 2022 |
15.66% |
| Mar 31, 2022 |
-91.61% |
| Dec 31, 2021 |
-1,802.29% |
| Sep 30, 2021 |
-3,633.37% |
| Jun 30, 2021 |
-2,695.68% |
